Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects

Bibliography

• Ossemann M, Bruls E, de Borchgrave V, Guidelines for the management of epilepsy in the elderly. Acta Neurol Belg 2006;8:111-16
   Google Scholar
• Sander JW, Hart YM, Johnson AL, Shorvon SD. National general practice study of epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990;336:1267-71
   PubMed Web of Science ®Google Scholar
• Hopwood MJ. Psychotropic medication use in older people. J Pharm Pract Res 2007;37:153-6
   Google Scholar
• Johnell K, Fastbom J. Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1 300 000 older people. Eur J Clin Pharmacol 2011; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Gomez-Pavon J, Gonzalez Garcia P, Frances Roman I, Recommendations for the prevention of adverse drug reactions in older adults with dementia. Rev Esp Geriatr Gerontol 2010;45:89-96
   PubMedGoogle Scholar
• Rivera R, Antognini JF. Perioperative drug therapy in elderly patients. Anesthesiology 2009;110:1176-81
   PubMed Web of Science ®Google Scholar
• Harms SL, Eberly LE, Garrard JM, Prevalence of appropriate and problematic antiepileptic combination therapy in older people in the nursing home. J Am Geriatr Soc 2005;53:1023-8
   PubMed Web of Science ®Google Scholar
• Arain AM, Abou-Khalil BW. Management of new-onset epilepsy in the elderly. Nat Rev Neurol 2009;5:363-71
   PubMed Web of Science ®Google Scholar
• Jose VM, Bhansali A, Hota D, Pandhi P. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabet Med 2007;24:377-83
   PubMed Web of Science ®Google Scholar
• Arif H, Buchsbaum R, Weintraub D, Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007;68:1701-9
   PubMed Web of Science ®Google Scholar
• Stefan H, Hubbertz L, Peglau I, Epilepsy outcomes in elderly treated with topiramate. Acta Neurol Scand 2008;118:164-74
   PubMed Web of Science ®Google Scholar
• Sommer BR, Fenn HH. Review of topiramate for the treatment of epilepsy in elderly patients. Clin Interv Aging 2010;5:89-99
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999;37:81-7
   PubMed Web of Science ®Google Scholar
• Saetre E, Perucca E, Isojarvi J, An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007;48:1292-302
   PubMed Web of Science ®Google Scholar
• Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 1994;35:181-8
   PubMed Web of Science ®Google Scholar
• Valentini S, Arbaizar-Rodriguez P, Abarca-Costalago M, Severe hyponatremia by oxcarbazepine in an elderly. Rev Neurol 2009;48:614-15
   PubMed Web of Science ®Google Scholar
• Gumbrevicius G, Sveikata A. A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine. Medicina (Kaunas) 2006;42:649-52
   PubMedGoogle Scholar
• Dogan EA, Usta BE, Bilgen R, Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. Epilepsy Behav 2008;13:156-61
   PubMed Web of Science ®Google Scholar
• Ortenzi A, Paggi A, Foschi N, Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy. Funct Neurol 2008;23:97-100
   PubMed Web of Science ®Google Scholar
• Kutluay E, McCague K, D'Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003;4:175-80
   PubMed Web of Science ®Google Scholar
• Chaudhry MM, Abrar M, Mutahir K, Mendoza C. Oxcarbazepine-induced hemolytic anemia in a geriatric patient. Am J Ther 2008;15:187-9
   PubMed Web of Science ®Google Scholar
• Mahmud J, Mathews M, Verma S, Basil B. Oxcarbazepine-induced thrombocytopenia. Psychosomatics 2006;47:73-4
   PubMed Web of Science ®Google Scholar
• Evans BK, Kustra RP, Hammer AE. Assessment of tolerability in elderly patients: changing to lamotrigine therapy. Am J Geriatr Pharmacother 2007;5:112-19
   PubMedGoogle Scholar
• Rowan AJ, Ramsay RE, Collins JF, New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-73
   PubMed Web of Science ®Google Scholar
• Craig I, Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 1994;35:381-90
   PubMed Web of Science ®Google Scholar
• Martin R, Meador K, Turrentine L, Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia 2001;42:764-71
   PubMed Web of Science ®Google Scholar
• VanCott AC, Cramer JA, Copeland LA, Suicide-related behaviors in older patients with new anti epileptic drug use: data from the VA hospital system. BMC Med 2010;8:4
   PubMed Web of Science ®Google Scholar
• Kemp DE, Gilmer WS, Fleck J, Dago PL. An association of intrusive, repetitive phrases with lamotrigine treatment in bipolar II disorder. CNS Spectr 2007;12:106-11
   PubMed Web of Science ®Google Scholar
• York RC, Coleridge ST. Cardiopulmonary arrest following intravenous phenytoin loading. Am J Emerg Med 1988;6:255-9
   PubMed Web of Science ®Google Scholar
• Bedichek E, Kirschbaum B. A case of propylene glycol toxic reaction associated with etomidate infusion. Arch Intern Med 1991;151:2297-8
   PubMed Web of Science ®Google Scholar
• Adams BD, Buckley NH, Kim JY, Tipps LB. Fosphenytoin may cause hemodynamically unstable bradydysrhythmias. J Emerg Med 2006;30:75-9
   PubMed Web of Science ®Google Scholar
• Fattouch J, Di Bonaventura C, Casciato S, Intravenous levetiracetam as first-line treatment of status epilepticus in the elderly. Acta Neurol Scand 2010;121:418-21
   PubMed Web of Science ®Google Scholar
• Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011;52:1292-6
   PubMed Web of Science ®Google Scholar
• Hofler J, Unterberger I, Dobesberger J, Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 2011; Epub ahead of print
   PubMedGoogle Scholar
• Erdogan G, Ceyhan D, Gulec S. Possible heart failure associated with pregabalin use: case report. Agri 2011;23:80-3
   PubMedGoogle Scholar
• Page RL II, Cantu M, Lindenfeld J, Possible heart failure exacerbation associated with pregabalin: case discussion and literature review. J Cardiovasc Med (Hagerstown) 2008;9:922-5
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial. JAMA 1998;280:1837-42
   PubMed Web of Science ®Google Scholar
• Cloyd JC, Lackner TE, Leppik IE. Antiepileptics in elderly patients. Pharmacoepidemiol Pharmacokinet Arch Fam Med 1994;3:589-98
   Google Scholar
• Jette N, Lix LM, Metge CJ, Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol 2011;68:107-12
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs 2001;15:633-42
   PubMed Web of Science ®Google Scholar
• Heo K, Rhee Y, Lee HW, The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. Epilepsia 2011;52:1884-9
   PubMed Web of Science ®Google Scholar
• Souverein PC, Webb DJ, Weil JG, Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology 2006;66:1318-24
   PubMed Web of Science ®Google Scholar
• Perreault S, Dragomir A, Blais L, Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture. Pharmacoepidemiol Drug Saf 2008;17:248-59
   PubMed Web of Science ®Google Scholar
• Pack AM, Gidal B, Vazquez B. Bone disease associated with antiepileptic drugs. Cleve Clin J Med 2004;71(Suppl 2):S42-8
   PubMedGoogle Scholar
• Fife TD, Blum D, Fisher RS. Measuring the effects of antiepileptic medications on balance in older people. Epilepsy Res 2006;70:103-9
   PubMed Web of Science ®Google Scholar
• Kaufman DW, Kelly JP, Anderson T, Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia 1997;38:1265-9
   PubMed Web of Science ®Google Scholar
• O'Neil MG, Perdun CS, Wilson MB, Felbamate-associated fatal acute hepatic necrosis. Neurology 1996;46:1457-9
   PubMed Web of Science ®Google Scholar
• No authors listed Acute liver failure linked to felbamate use. Am J Hosp Pharm 1994;51:2882-7
   PubMedGoogle Scholar
• Leeder JS. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 1998;39(Suppl 7):S8-16
   Google Scholar
• Pugh MJ, Vancott AC, Steinman MA, Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications. Am Geriatr Soc 2010;58:465-71
   PubMed Web of Science ®Google Scholar
• Van der Lee MJ, Dawood L, ter Hofstede HJ, Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects. Clin Pharmacol Ther 2006;80:159-68
   PubMed Web of Science ®Google Scholar
• Mueller TH, Beeber AR. Delirium from valproic acid with lamotrigine. Am J Psychiatry 2004;161:1128-9
   PubMed Web of Science ®Google Scholar
• May TW, Rambeck B, Jurgens U. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication. Ther Drug Monit 1996;18:523-31
   PubMed Web of Science ®Google Scholar
• Burneo JG, Limdi N, Kuzniecky RI, Neurotoxicity following addition of intravenous valproate to lamotrigine therapy. Neurology 2003;60:1991-2
   PubMed Web of Science ®Google Scholar
• Kanner AM, Frey M. Adding valproate to lamotrigine: a study of their pharmacokinetic interaction. Neurology 2000;55:588-91
   PubMed Web of Science ®Google Scholar
• Banfield CR, Zhu GR, Jen JF, The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling. Ther Drug Monit 1996;18:19-29
   PubMed Web of Science ®Google Scholar
• Graves NM, Holmes GB, Fuerst RH, Leppik IE. Effect of felbamate on phenytoin and carbamazepine serum concentrations. Epilepsia 1989;30:225-9
   PubMed Web of Science ®Google Scholar
• Sachdeo R, Wagner ML, Sachdeo S, Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate. Epilepsia 1999;40:1122-8
   PubMed Web of Science ®Google Scholar
• Sachdeo RC, Sachdeo SK, Walker SA, Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 1996;37:774-80
   PubMed Web of Science ®Google Scholar
• Mack CJ, Kuc S, Mulcrone SA, Interaction of topiramate with carbamazepine: two case reports and a review of clinical experience. Seizure 2002;11:464-7
   PubMed Web of Science ®Google Scholar
• Vucicevic K, Miljkovic B, Pokrajac M, The influence of drug-drug interaction and patients' characteristics on valproic acid's clearance in adults with epilepsy using nonlinear mixed effects modeling. Eur J Pharm Sci 2009;38:512-18
   PubMed Web of Science ®Google Scholar
• Knudsen JF, Sokol GH, Flowers CM. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy. J Clin Pharm Ther 2008;33:513-19
   PubMed Web of Science ®Google Scholar
• Birnbaum AK, Ahn JE, Brundage RC, Population pharmacokinetics of valproic acid concentrations in elderly nursing home residents. Ther Drug Monit 2007;29:571-5
   PubMed Web of Science ®Google Scholar
• Gu J, Huang Y. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient. Am J Geriatr Pharmacother 2009;7:26-33
   PubMed Web of Science ®Google Scholar
• Fudio S, Carcas A, Pinana E, Ortega R. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. J Clin Pharm Ther 2006;31:393-6
   PubMed Web of Science ®Google Scholar
• Cabanes Mariscal MA, Sanchez Lopez P, Alvarez Herranz P, Chamorro Merino G. Pharmacokinetic interaction between valproic acid and ertapenem. Farm Hosp 2006;30:313-15
   PubMedGoogle Scholar
• Gidal BE, Baltes E, Otoul C, Perucca E. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials. Epilepsy Res 2005;64:1-11
   PubMed Web of Science ®Google Scholar
• Coupez R, Nicolas JM, Browne TR. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid. Epilepsia 2003;44:171-8
   PubMed Web of Science ®Google Scholar
• Gustavson LE, Cato A III, Boellner SW, Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin. Am J Ther 1998;5:9-16
   PubMedGoogle Scholar
• Gustavson LE, Sommerville KW, Boellner SW, Lack of a clinically significant pharmacokinetic drug interaction between tiagabine and valproate. Am J Ther 1998;5:73-9
   PubMedGoogle Scholar
• Thomsen MS, Groes L, Agersø H, Kruse T. Lack of pharmacokinetic interaction between tiagabine and erythromycin. J Clin Pharmacol 1998;38:1051-6
   PubMed Web of Science ®Google Scholar
• Ragueneau-Majlessi I, Levy RH, Bergen D, Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. Epilepsy Res 2004;62:1-11
   PubMed Web of Science ®Google Scholar
• Levy RH, Ragueneau-Majlessi I, Garnett WR, Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy. J Clin Pharmacol 2004;44:1230-4
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Wilson EA, Wesche DL, Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 2005;46:1407-13
   PubMed Web of Science ®Google Scholar
• Almeida L, Nunes T, Sicard E, Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects. Acta Neurol Scand 2010;121:257-64
   PubMed Web of Science ®Google Scholar
• Nunes T, Sicard E, Almeida L, Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects. Curr Med Res Opin 2010;26:1355-62
   PubMed Web of Science ®Google Scholar
• Gidal B, Anderson G. Epilepsy in the elderly: special pharmacotherapeutic considerations. Consult Pharm 1998;1:62-74
   Google Scholar
• Koyama H, Sugioka N, Uno A, Age-related alteration of carbamazepine-serum protein binding in man. J Pharm Pharmacol 1999;51:1009-14; 70
   PubMed Web of Science ®Google Scholar
• Stephen LJ. Drug treatment of epilepsy in elderly people: focus on valproic acid. Drugs Aging 2003;20:141-52
   PubMed Web of Science ®Google Scholar
• Perucca E, Grimaldi R, Gatti G, Pharmacokinetics of valproic acid in the elderly. Br J Clin Pharmacol 1984;17:665-9
   PubMed Web of Science ®Google Scholar
• Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004;62(5 Suppl 2):S24-9
   PubMed Web of Science ®Google Scholar
• Graves NM, Brundage RC, Wen Y, Population pharmacokinetics of carbamazepine in adults with epilepsy. Pharmacotherapy 1998;18:273-81
   PubMed Web of Science ®Google Scholar
• Eadie MJ, Lander CM, Hooper WD, Tyrer JH. Factors influencing plasma phenobarbitone levels in epileptic patients. Br J Clin Pharmacol 1977;4:541-7
   PubMed Web of Science ®Google Scholar
• Lackner TE. Strategies for optimizing antiepileptic drug therapy in elderly people. Pharmacotherapy 2002;22:329-64
   PubMed Web of Science ®Google Scholar
• Punyawudho B, Ramsay RE, Macias FM, Population pharmacokinetics of lamotrigine in elderly patients. J Clin Pharmacol 2008;48:455-63
   PubMed Web of Science ®Google Scholar
• Milovanovic JR, Jankovic SM. Population pharmacokinetics of lamotrigine in patients with epilepsy. Int J Clin Pharmacol Ther 2009;47:752-60
   PubMed Web of Science ®Google Scholar
• May TW, Rambeck B, Neb R, Jurgens U. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication. Ther Drug Monit 2007;29:789-94
   PubMed Web of Science ®Google Scholar
• Richens A, Banfield CR, Salfi M, Single and multiple dose pharmacokinetics of felbamate in the elderly. Br J Clin Pharmacol 1997;44:129-34
   PubMed Web of Science ®Google Scholar
• Posner J, Holdich T, Chrome P. Comparison of lamotrigine pharmacokinetics in young and elderly healthy volunteers. J Pharm Med 1991;1:121-8
   Google Scholar
• Goa KL, Ross SR, Chrisp P. Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46:152-76
   PubMed Web of Science ®Google Scholar
• Doose DR, Larsson KL, Natarajan J, Comparative single-dose pharmacokinetics of topiramate in elderly versus young men and women. Epilepsia 1998;39(Suppl 6):56
   Google Scholar
• Pack AM. Treatment of epilepsy to optimize bone health. Curr Treat Options Neurol 2011;13:346-54
   PubMed Web of Science ®Google Scholar
• Asconape JJ. Some common issues in the use of antiepileptic drugs. Semin Neurol 2002;22:27-39
   PubMed Web of Science ®Google Scholar
• Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003;2:473-81
   PubMed Web of Science ®Google Scholar
• Leppik IE, Birnbaum AK. Epilepsy in the elderly. Ann NY Acad Sci 2010;1184:208-24
   PubMed Web of Science ®Google Scholar
• Perucca E, Berlowitz D, Birnbaum A, Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 2006;68(Suppl 1):S49-63
   PubMed Web of Science ®Google Scholar